skip to Main Content

Dr. Bekaii-Saab on Napabucasin in Patients With Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
  Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses the potential of napabucasin, previously known as BBI-608, in patients with pancreatic cancer.
  Watch and listen here . . .

Back To Top